Adaptive Biotechnologies Corporation functions as a biotechnology entity. Specialising in the immune system and disease diagnostics, it operates across the US. The company uses advanced technology to read and translate the genetics of the adaptive immune system, providing essential insights into human health and disease.
Operating within the biotechnology industry, Adaptive Biotechnologies works in the field of immune-driven medicine. The company's services extend to diagnostic products that can detect a range of diseases, aiding healthcare providers and patients in proactive disease management.
Stay up to date on the share price of ADPT by adding it to your eToro watchlist.